Table of Contents Author Guidelines Submit a Manuscript
Pain Research and Management
Volume 2019, Article ID 7490801, 12 pages
https://doi.org/10.1155/2019/7490801
Review Article

Risk Factors and Prevention Strategies for Postoperative Opioid Abuse

1Department of Anesthesiology, First Hospital of Jilin University, Changchun, China
2Department of Neurosurgery, First Hospital of Jilin University, Changchun, China
3Department of Anesthesiology, Second Hospital of Xi’an Jiaotong University, Xi’an, China

Correspondence should be addressed to Wei Han; moc.uhos@sykzmyydj and Yuan Zhang; moc.361@00251034881

Received 26 October 2018; Accepted 25 June 2019; Published 10 July 2019

Academic Editor: Robert L. Barkin

Copyright © 2019 Shuai Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Bendixen, O. D. Jørgensen, C. Kronborg, C. Andersen, and P. B. Licht, “Postoperative pain and quality of life after lobectomy via video-assisted thoracoscopic surgery or anterolateral thoracotomy for early stage lung cancer: a randomised controlled trial,” The Lancet Oncology, vol. 17, no. 6, pp. 836–844, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. E. O. Bayman, K. R. Parekh, J. Keech, N. Larson, M. V. Weg, and T. J. Brennan, “Preoperative patient expectations of postoperative pain are associated with moderate to severe acute pain after VATS,” Pain Medicine, vol. 20, no. 3, pp. 543–554, 2018. View at Publisher · View at Google Scholar · View at Scopus
  3. E. O. Bayman, K. R. Parekh, J. Keech, A. Selte, and T. J. Brennan, “A prospective study of chronic pain after thoracic surgery,” Anesthesiology, vol. 126, no. 5, pp. 938–951, 2017. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Wunsch, D. N. Wijeysundera, M. A. Passarella, and M. D. Neuman, “Opioids prescribed after low-risk surgical procedures in the United States, 2004–2012,” JAMA, vol. 315, no. 15, pp. 1654–1657, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. F. W. Abdallah, P. J. Morgan, T. Cil et al., “Ultrasound-guided multilevel paravertebral blocks and total intravenous anesthesia improve the quality of recovery after ambulatory breast tumor resection,” Anesthesiology, vol. 120, no. 3, pp. 703–713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Takagi, R. Yoshida, T. Yagi et al., “Effect of an enhanced recovery after surgery protocol in patients undergoing pancreaticoduodenectomy: a randomized controlled trial,” Clinical Nutrition, vol. 38, no. 1, pp. 174–181, 2019. View at Publisher · View at Google Scholar · View at Scopus
  7. R. A. Azhar, B. Bochner, J. Catto et al., “Enhanced recovery after urological surgery: a contemporary systematic review of outcomes, key elements, and research needs,” European Urology, vol. 70, no. 1, pp. 176–187, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. T. J. Gan, “Poorly controlled postoperative pain: prevalence, consequences, and prevention,” Journal of Pain Research, vol. 10, pp. 2287–2298, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. Z. D. Post, “CORR insights®: preoperative opioid misuse is associated with increased morbidity and mortality after elective orthopaedic surgery,” Clinical Orthopaedics and Related Research, vol. 473, no. 7, pp. 2413-2414, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. S. A. Pathan, B. Mitra, and P. A. Cameron, “A systematic review and meta-analysis comparing the efficacy of nonsteroidal anti-inflammatory drugs, opioids, and paracetamol in the treatment of acute renal colic,” European Urology, vol. 73, no. 4, pp. 583–595, 2018. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Camilleri, A. Lembo, and D. A. Katzka, “Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits,” Clinical Gastroenterology and Hepatology, vol. 15, no. 9, pp. 1338–1349, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Els, T. D. Jackson, D. Kunyk et al., “Adverse events associated with medium- and long-term use of opioids for chronic non-cancer pain: an overview of Cochrane reviews,” Cochrane Database of Systematic Reviews, vol. 10, Article ID CD012509, 2017. View at Publisher · View at Google Scholar · View at Scopus
  13. C. A. Verberkt, M. H. J. van den Beuken-van Everdingen, J. M. G. A. Schols et al., “Respiratory adverse effects of opioids for breathlessness: a systematic review and meta-analysis,” European Respiratory Journal, vol. 50, no. 5, Article ID 1701153, 2017. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Shafi, A. W. Collinsworth, L. A. Copeland et al., “Association of opioid-related adverse drug events with clinical and cost outcomes among surgical patients in a large integrated health care delivery system,” JAMA Surgery, vol. 153, no. 8, pp. 757–763, 2018. View at Publisher · View at Google Scholar · View at Scopus
  15. G. A. Brat, D. Agniel, A. Beam et al., “Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study,” British Medical Journal, vol. 360, p. j5790, 2018. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Cao, R. Karmouta, D. G. Li, R. S. Din, and A. Mostaghimi, “Opioid prescribing patterns and complications in the dermatology medicare population,” JAMA Dermatology, vol. 154, no. 3, pp. 317–322, 2018. View at Publisher · View at Google Scholar · View at Scopus
  17. J. H. Ishida, C. E. McCulloch, M. A. Steinman, B. A. Grimes, and K. L. Johansen, “Opioid analgesics and adverse outcomes among hemodialysis patients,” Clinical Journal of the American Society of Nephrology, vol. 13, no. 5, pp. 746–753, 2018. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Katakami, K. Oda, K. Tauchi et al., “Phase IIb, randomized, double-blind, placebo-controlled study of naldemedine for the treatment of opioid-induced constipation in patients with cancer,” Journal of Clinical Oncology, vol. 35, no. 17, pp. 1921–1928, 2017. View at Publisher · View at Google Scholar · View at Scopus
  19. L. A. Lee, R. A. Caplan, L. S. Stephens et al., “Postoperative opioid-induced respiratory depression,” Anesthesiology, vol. 122, no. 3, pp. 659–665, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. L. M. Fox, R. S. Hoffman, D. Vlahov, and A. F. Manini, “Risk factors for severe respiratory depression from prescription opioid overdose,” Addiction, vol. 113, no. 1, pp. 59–66, 2018. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Hamina, H. Taipale, A. Tanskanen et al., “Long-term use of opioids for nonmalignant pain among community-dwelling persons with and without alzheimer disease in Finland,” Pain, vol. 158, no. 2, pp. 252–260, 2017. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. Song, “Mortality quadrupled among opioid-driven hospitalizations, notably within lower-income and disabled white populations,” Health Affairs, vol. 36, no. 12, pp. 2054–2061, 2017. View at Publisher · View at Google Scholar · View at Scopus
  23. J. R. Gaither, J. M. Leventhal, S. A. Ryan, and D. R. Camenga, “National trends in hospitalizations for opioid poisonings among children and adolescents, 1997 to 2012,” JAMA Pediatrics, vol. 170, no. 12, pp. 1195–1201, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. C. E. Cauley, G. Anderson, A. B. Haynes, M. Menendez, B. T. Bateman, and K. Ladha, “Predictors of in-hospital postoperative opioid overdose after major elective operations,” Annals of Surgery, vol. 265, no. 4, pp. 702–708, 2017. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Seth, L. Scholl, R. A. Rudd, and S. Bacon, “Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015-2016,” MMWR. Morbidity and Mortality Weekly Report, vol. 67, no. 12, pp. 349–358, 2018. View at Publisher · View at Google Scholar · View at Scopus
  26. R. A. Rudd, N. Aleshire, J. E. Zibbell, and R. M. Gladden, “Increases in drug and opioid overdose deaths—United States, 2000–2014,” MMWR. Morbidity and Mortality Weekly Report, vol. 64, no. 50-51, pp. 1378–1382, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. C. D. Soelberg, R. E. Brown Jr., D. D. Vivier, J. Meyer, and B. Ramachandran, “The US opioid crisis,” Anesthesia & Analgesia, vol. 125, no. 5, pp. 1675–1681, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. P. D. Friedmann, C. M. Andrews, and K. Humphreys, “How ACA repeal would worsen the opioid epidemic,” New England Journal of Medicine, vol. 376, no. 10, p. e16, 2017. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Vu and L. Lin, “Opioid overdose—the surgeonʼs role,” Annals of Surgery, vol. 268, no. 1, pp. 32–34, 2018. View at Publisher · View at Google Scholar · View at Scopus
  30. L. R. Webster, “Risk factors for opioid-use disorder and overdose,” Anesthesia & Analgesia, vol. 125, no. 5, pp. 1741–1748, 2017. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Terplan, “Women and the opioid crisis: historical context and public health solutions,” Fertility and Sterility, vol. 108, no. 2, pp. 195–199, 2017. View at Publisher · View at Google Scholar · View at Scopus
  32. F. L. Beaudoin, R. Gutman, W. Zhai et al., “Racial differences in presentations and predictors of acute pain after motor vehicle collision,” Pain, vol. 159, no. 6, pp. 1056–1063, 2018. View at Publisher · View at Google Scholar · View at Scopus
  33. C. W. Swenson, N. S. Kamdar, K. Seiler, D. M. Morgan, P. Lin, and S. As-Sanie, “Definition development and prevalence of new persistent opioid use following hysterectomy,” American Journal of Obstetrics and Gynecology, vol. 219, no. 5, pp. 486.e1–486.e7, 2018. View at Publisher · View at Google Scholar · View at Scopus
  34. Y.-F. Kuo, M. A. Raji, N.-W. Chen, H. Hasan, and J. S. Goodwin, “Trends in opioid prescriptions among part D medicare recipients from 2007 to 2012,” American Journal of Medicine, vol. 129, no. 2, pp. 221.e21–221.e30, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. H. Clarke, N. Soneji, D. T. Ko, L. S. Yun, and D. N. Wijeysundera, “Rates and risk factors for prolonged opioid use after major surgery: population based cohort study,” British Medical Journal, vol. 348, no. 3, p. g1251, 2014. View at Publisher · View at Google Scholar · View at Scopus
  36. A. H. Smith, K. P. Jensen, J. Li et al., “Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1,” Molecular Psychiatry, vol. 22, no. 3, pp. 346–352, 2017. View at Publisher · View at Google Scholar · View at Scopus
  37. M. De Gregori, L. Diatchenko, P. M. Ingelmo et al., “Human genetic variability contributes to postoperative morphine consumption,” Journal of Pain, vol. 17, no. 5, pp. 628–636, 2016. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Doehring, N. Küsener, K. Flühr, T. J. Neddermeyer, G. Schneider, and J. Lotsch, “Effect sizes in experimental pain produced by gender, genetic variants and sensitization procedures,” PLoS One, vol. 6, no. 3, Article ID e17724, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. O. Levran, D. Londono, K. O’Hara et al., “Genetic susceptibility to heroin addiction: a candidate gene association study,” Genes, Brain and Behavior, vol. 7, no. 7, pp. 720–729, 2008. View at Publisher · View at Google Scholar · View at Scopus
  40. T. Kishi, R. Yoshimura, T. Okochi et al., “Association analysis of SIGMAR1 with major depressive disorder and SSRI response,” Neuropharmacology, vol. 58, no. 7, pp. 1168–1173, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. T.-K. Clarke, R. C. Crist, K. M. Kampman et al., “Low frequency genetic variants in the μ-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine,” Neuroscience Letters, vol. 542, pp. 71–75, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. S. A. Shabalina, D. V. Zaykin, P. Gris et al., “Expansion of the human μ-opioid receptor gene architecture: novel functional variants,” Human Molecular Genetics, vol. 18, no. 6, pp. 1037–1051, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Bond, K. S. LaForge, M. Tian et al., “Single-nucleotide polymorphism in the human mu opioid receptor gene alters β-endorphin binding and activity: possible implications for opiate addiction,” Proceedings of the National Academy of Sciences, vol. 95, no. 16, pp. 9608–9613, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. S.-C. Wang, H.-H. Tsou, C.-H. Chen et al., “Genetic polymorphisms in the opioid receptor mu1 gene are associated with changes in libido and insomnia in methadone maintenance patients,” European Neuropsychopharmacology, vol. 22, no. 10, pp. 695–703, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. G. Lettre, C. D. Palmer, T. Young et al., “Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe project,” PLoS Genetics, vol. 7, no. 2, Article ID e1001300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. D. Kringel, A. Ultsch, M. Zimmermann et al., “Emergent biomarker derived from next-generation sequencing to identify pain patients requiring uncommonly high opioid doses,” Pharmacogenomics Journal, vol. 17, no. 5, pp. 419–426, 2017. View at Publisher · View at Google Scholar · View at Scopus
  47. R. Donaldson, Y. Sun, D.-Y. Liang et al., “The multiple PDZ domain protein Mpdz/MUPP1 regulates opioid tolerance and opioid-induced hyperalgesia,” BMC Genomics, vol. 17, no. 1, p. 313, 2016. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Aubrun, N. Zahr, O. Langeron et al., “Opioid-related genetic polymorphisms do not influence postoperative opioid requirement: a prospective observational study,” European Journal of Anaesthesiology, vol. 35, pp. 496–504, 2018. View at Publisher · View at Google Scholar · View at Scopus
  49. E. C. Sun, B. D. Darnall, L. C. Baker, and S. Mackey, “Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period,” JAMA Internal Medicine, vol. 176, no. 9, pp. 1286–1293, 2016. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Khor, D. Lavallee, A. M. Cizik et al., “Development and validation of a prediction model for pain and functional outcomes after lumbar spine surgery,” JAMA Surgery, vol. 153, no. 7, pp. 634–642, 2018. View at Publisher · View at Google Scholar · View at Scopus
  51. J. Ditre, B. Gonzalez, V. Simmons, L. Faul, T. Brandon, and P. Jacobsen, “Associations between pain and current smoking status among cancer patients,” Pain, vol. 152, no. 1, pp. 60–65, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. H. L. Logan, R. B. Fillingim, L. M. Bartoshuk et al., “Smoking status and pain level among head and neck cancer patients,” Journal of Pain, vol. 11, no. 6, pp. 528–534, 2010. View at Publisher · View at Google Scholar · View at Scopus
  53. B. T. Bateman, J. M. Franklin, K. Bykov et al., “Persistent opioid use following Cesarean delivery: patterns and predictors among opioid naïve women,” American Journal of Obstetrics and Gynecology, vol. 215, no. 3, pp. 353.e351–353.e318, 2016. View at Publisher · View at Google Scholar · View at Scopus
  54. C. M. Brummett, J. F. Waljee, J. Goesling et al., “New persistent opioid use after minor and major surgical procedures in US adults,” JAMA Surgery, vol. 152, no. 6, Article ID e170504, 2017. View at Publisher · View at Google Scholar · View at Scopus
  55. M. S. Aydogan, E. Ozturk, M. A. Erdogan et al., “The effects of secondhand smoke on postoperative pain and fentanyl consumption,” Journal of Anesthesia, vol. 27, no. 4, pp. 569–574, 2013. View at Publisher · View at Google Scholar · View at Scopus
  56. S. J. van Erp, L. K. Brakenhoff, F. A. van Gaalen et al., “Classifying back pain and peripheral joint complaints in inflammatory bowel disease patients: a prospective longitudinal follow-up study,” Journal of Crohn's and Colitis, vol. 10, no. 2, pp. 166–175, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. M. L. Davies-Tuck, A. E. Wluka, A. Forbes et al., “Smoking is associated with increased cartilage loss and persistence of bone marrow lesions over 2 years in community-based individuals,” Rheumatology, vol. 48, no. 10, pp. 1227–1231, 2009. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Lahiri, C. Morgan, D. P. M. Symmons, and I. N. Bruce, “Modifiable risk factors for RA: prevention, better than cure?” Rheumatology, vol. 51, no. 3, pp. 499–512, 2012. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Saevarsdottir, S. Wedrén, M. Seddighzadeh et al., “Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: observations from the epidemiological investigation of rheumatoid arthritis and the swedish rheumatology reg,” Arthritis & Rheumatism, vol. 63, no. 1, pp. 26–36, 2011. View at Publisher · View at Google Scholar · View at Scopus
  60. J. W. Ditre, B. W. Heckman, E. L. Zale, J. D. Kosiba, and S. A. Maisto, “Acute analgesic effects of nicotine and tobacco in humans: a meta-analysis,” Pain, vol. 157, no. 7, pp. 1373–1381, 2016. View at Publisher · View at Google Scholar · View at Scopus
  61. E. Rydell, K. Forslind, J-A. Nilsson, L. T. H. Jacobsson, and C. Turesson, “Smoking, body mass index, disease activity, and the risk of rapid radiographic progression in patients with early rheumatoid arthritis,” Arthritis Research & Therapy,, vol. 20, no. 1, 2018. View at Publisher · View at Google Scholar · View at Scopus
  62. I. Delgado-Enciso, B. Paz-Michel, V. Melnikov et al., “Smoking and female sex as key risk factors associated with severe arthralgia in acute and chronic phases of chikungunya virus infection,” Experimental and Therapeutic Medicine, vol. 15, pp. 2634–2642, 2017. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Wang, T. Wang, Q. Wang, and W. Ding, “Incidence and risk factors of persistent low back pain following posterior decompression and instrumented fusion for lumbar disk herniation,” Journal of Pain Research, vol. 10, pp. 1019–1025, 2017. View at Publisher · View at Google Scholar · View at Scopus
  64. S. Momi, S. Fabiane, G. Lachance, G. Livshits, and F. M. Williams, “Neuropathic pain as part of chronic widespread pain,” Pain, vol. 156, no. 10, pp. 2100–2106, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. A. Yosef, C. Allaire, C. Williams et al., “Multifactorial contributors to the severity of chronic pelvic pain in women,” American Journal of Obstetrics & Gynecology, vol. 215, no. 6, pp. 760.e1–760.e14, 2016. View at Publisher · View at Google Scholar · View at Scopus
  66. I. N. Ackerman, E. Zomer, J. F.-M. Gilmartin-Thomas, and D. Liew, “Forecasting the future burden of opioids for osteoarthritis,” Osteoarthritis and Cartilage, vol. 26, no. 3, pp. 350–355, 2018. View at Publisher · View at Google Scholar · View at Scopus
  67. M. Olfson, M. M. Wall, S.-M. Liu, and C. Blanco, “Cannabis use and risk of prescription opioid use disorder in the United States,” American Journal of Psychiatry, vol. 175, no. 1, pp. 47–53, 2018. View at Publisher · View at Google Scholar · View at Scopus
  68. T. G. Weiser, A. B. Haynes, G. Molina et al., “Size and distribution of the global volume of surgery in 2012,” Bulletin of the World Health Organization, vol. 94, no. 3, pp. 201F–209F, 2016. View at Publisher · View at Google Scholar · View at Scopus
  69. C. Blanco, M. M. Wall, M. Okuda, S. Wang, M. Iza, and M. Olfson, “Pain as a predictor of opioid use disorder in a nationally representative sample,” American Journal of Psychiatry, vol. 173, no. 12, pp. 1189–1195, 2016. View at Publisher · View at Google Scholar · View at Scopus
  70. M. A. Chaudhary, A. J. Schoenfeld, A. F. Harlow et al., “Incidence and predictors of opioid prescription at discharge after traumatic injury,” JAMA Surgery, vol. 152, no. 10, pp. 930–936, 2017. View at Publisher · View at Google Scholar · View at Scopus
  71. E. C. Wick, M. C. Grant, and C. L. Wu, “Postoperative multimodal analgesia pain management with nonopioid analgesics and techniques,” JAMA Surgery, vol. 152, no. 7, pp. 691–697, 2017. View at Publisher · View at Google Scholar · View at Scopus
  72. H.-L. Chiang, Y.-Y. Chia, H.-S. Lin, and C.-H. Chen, “The implications of tobacco smoking on acute postoperative pain: a prospective observational study,” Pain Research & Management, vol. 2016, Article ID 9432493, 7 pages, 2016. View at Publisher · View at Google Scholar · View at Scopus
  73. J. S.-J. Lee, H. M. Hu, A. L. Edelman et al., “New persistent opioid use among patients with cancer after curative-intent surgery,” Journal of Clinical Oncology, vol. 35, no. 36, pp. 4042–4049, 2017. View at Publisher · View at Google Scholar · View at Scopus
  74. M. D. Sullivan, A. M. Bauer, D. Fulton-Kehoe et al., “Trends in opioid dosing among Washington state medicaid patients before and after opioid dosing guideline implementation,” Journal of Pain, vol. 17, no. 5, pp. 561–568, 2016. View at Publisher · View at Google Scholar · View at Scopus
  75. M. de la Cruz, A. Reddy, V. Balankari et al., “The impact of an educational program on patient practices for safe use, storage, and disposal of opioids at a comprehensive cancer center,” The Oncologist, vol. 22, no. 1, pp. 115–121, 2017. View at Publisher · View at Google Scholar · View at Scopus
  76. W. M. Hooten, “Chronic pain and mental health disorders,” Mayo Clinic Proceedings, vol. 91, no. 7, pp. 955–970, 2016. View at Publisher · View at Google Scholar · View at Scopus
  77. N. Soneji, H. A. Clarke, D. T. Ko, and D. N. Wijeysundera, “Risks of developing persistent opioid use after major surgery,” JAMA Surgery, vol. 151, no. 11, pp. 1083-1084, 2016. View at Publisher · View at Google Scholar · View at Scopus
  78. K. G. Andersen, H. M. Duriaud, H. Kehlet, and E. K. Aasvang, “The relationship between sensory loss and persistent pain 1 year after breast cancer surgery,” Journal of Pain, vol. 18, no. 9, pp. 1129–1138, 2017. View at Publisher · View at Google Scholar · View at Scopus
  79. N. Sabourdin, J. Barrois, N. Louvet et al., “Pupillometry-guided intraoperative remifentanil administration versus standard practice influences opioid use: a randomized study,” Anesthesiology, vol. 127, no. 2, pp. 284–292, 2017. View at Publisher · View at Google Scholar · View at Scopus
  80. R. Edry, V. Recea, Y. Dikust, and D. Sessler, “Preliminary intraoperative validation of the nociception level index: a noninvasive nociception monitor,” Anesthesiology, vol. 125, no. 1, pp. 193–203, 2016. View at Publisher · View at Google Scholar · View at Scopus
  81. M. Murata-Ooiwa, S. Tsukada, and M. Wakui, “Intravenous acetaminophen in multimodal pain management for patients undergoing total knee arthroplasty: a randomized, double-blind, placebo-controlled trial,” Journal of Arthroplasty, vol. 32, no. 10, pp. 3024–3028, 2017. View at Publisher · View at Google Scholar · View at Scopus
  82. J. Haumann, J. W. Geurts, S. M. J. van Kuijk, B. Kremer, E. A. Joosten, and M. H. J. van den Beuken-van Everdingen, “Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer,” European Journal of Cancer, vol. 65, pp. 121–129, 2016. View at Publisher · View at Google Scholar · View at Scopus
  83. C. W. Cheung, Q. Qiu, A. C. L. Ying, S. W. Choi, W. L. Law, and M. G. Irwin, “The effects of intra-operative dexmedetomidine on postoperative pain, side-effects and recovery in colorectal surgery,” Anaesthesia, vol. 69, no. 11, pp. 1214–1221, 2014. View at Publisher · View at Google Scholar · View at Scopus
  84. K. Ouchi and K. Sugiyama, “Dexmedetomidine dose dependently enhances the local anesthetic action of lidocaine in inferior alveolar nerve block: a randomized double-blind study,” Regional Anesthesia and Pain Medicine, vol. 41, no. 3, pp. 348–355, 2016. View at Publisher · View at Google Scholar · View at Scopus
  85. A. Nader, M. C. Kendall, D. W. Manning et al., “Single-dose adductor canal block with local infiltrative analgesia compared with local infiltrate analgesia after total knee arthroplasty,” Regional Anesthesia and Pain Medicine, vol. 41, no. 6, pp. 678–684, 2016. View at Publisher · View at Google Scholar · View at Scopus
  86. D. M. Hall-Burton, M. E. Hudson, J. S. Grudziak, S. Cunningham, K. Boretsky, and K. R. Boretsky, “Regional anesthesia is cost-effective in preventing unanticipated hospital admission in pediatric patients having anterior cruciate ligament reconstruction,” Regional Anesthesia and Pain Medicine, vol. 41, no. 4, pp. 527–531, 2016. View at Publisher · View at Google Scholar · View at Scopus
  87. S. Derry, T. E. Cooper, and T. Phillips, “Single fixed-dose oral dexketoprofen plus tramadol for acute postoperative pain in adults,” Cochrane Database of Systematic Reviews, vol. 9, Article ID CD012232, 2016. View at Publisher · View at Google Scholar · View at Scopus
  88. H. A. Clarke, J. Katz, C. J. L. McCartney et al., “Perioperative gabapentin reduces 24 h opioid consumption and improves in-hospital rehabilitation but not post-discharge outcomes after total knee arthroplasty with peripheral nerve block,” British Journal of Anaesthesia, vol. 113, no. 5, pp. 855–864, 2014. View at Publisher · View at Google Scholar · View at Scopus
  89. N. Shimony, U. Amit, B. Minz et al., “Perioperative pregabalin for reducing pain, analgesic consumption, and anxiety and enhancing sleep quality in elective neurosurgical patients: a prospective, randomized, double-blind, and controlled clinical study,” Journal of Neurosurgery, vol. 125, no. 6, pp. 1513–1522, 2016. View at Publisher · View at Google Scholar · View at Scopus
  90. P. Dietze and K. Cantwell, “Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention,” Addiction, vol. 111, no. 4, pp. 584–586, 2016. View at Publisher · View at Google Scholar · View at Scopus
  91. C. A. Smith, K. M. Levett, C. T. Collins, M. Armour, H. G. Dahlen, and M. Suganuma, “Relaxation techniques for pain management in labour,” Cochrane Database of Systematic Reviews, vol. 3, Article ID CD009514, 2018. View at Publisher · View at Google Scholar · View at Scopus
  92. E. C. Sun, A. Dixit, K. Humphreys, B. D. Darnall, L. C. Baker, and S. Mackey, “Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis,” British Medical Journal, vol. 356, p. j760, 2017. View at Publisher · View at Google Scholar · View at Scopus
  93. P. D. Quinn, K. Hur, Z. Chang et al., “Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims,” Pain, vol. 158, no. 1, pp. 140–148, 2017. View at Publisher · View at Google Scholar · View at Scopus
  94. B. Halbert, R. Davis, and C. Wee, “Disproportionate longer-term opioid use among U.S. adults with mood disorders,” Pain, vol. 157, no. 11, pp. 2452–2457, 2016. View at Publisher · View at Google Scholar · View at Scopus
  95. Y. Finkelstein, E. M. Macdonald, A. Gonzalez et al., “Overdose risk in young children of women prescribed opioids,” Pediatrics, vol. 139, no. 3, Article ID e20162887, 2017. View at Publisher · View at Google Scholar · View at Scopus
  96. K. Kumar, L. V. Gulotta, J. S. Dines et al., “Unused opioid pills after outpatient shoulder surgeries given current perioperative prescribing habits,” American Journal of Sports Medicine, vol. 45, no. 3, pp. 636–641, 2017. View at Publisher · View at Google Scholar · View at Scopus
  97. B. C. Maughan, E. V. Hersh, F. S. Shofer et al., “Unused opioid analgesics and drug disposal following outpatient dental surgery: a randomized controlled trial,” Drug and Alcohol Dependence, vol. 168, pp. 328–334, 2016. View at Publisher · View at Google Scholar · View at Scopus
  98. O. Dyer, “Opioid manufacturer bribed doctors to prescribe fentanyl inappropriately, US says,” British Medical Journal, vol. 355, p. i6742, 2016. View at Publisher · View at Google Scholar · View at Scopus
  99. P. Dilokthornsakul, G. Moore, J. D. Campbell et al., “Risk factors of prescription opioid overdose among Colorado medicaid beneficiaries,” Journal of Pain, vol. 17, no. 4, pp. 436–443, 2016. View at Publisher · View at Google Scholar · View at Scopus
  100. J. A. Baker, J. Avorn, R. Levin, and B. T. Bateman, “Opioid prescribing after surgical extraction of teeth in medicaid patients, 2000–2010,” JAMA, vol. 315, no. 15, pp. 1653-1654, 2016. View at Publisher · View at Google Scholar · View at Scopus
  101. P. Moyo, L. Simoni-Wastila, B. A. Griffin et al., “Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among medicare beneficiaries in 10 US States,” Addiction, vol. 112, no. 10, pp. 1784–1796, 2017. View at Publisher · View at Google Scholar · View at Scopus
  102. E. Meara, J. R. Horwitz, W. Powell et al., “State legal restrictions and prescription-opioid use among disabled adults,” New England Journal of Medicine, vol. 375, no. 1, pp. 44–53, 2016. View at Publisher · View at Google Scholar · View at Scopus
  103. A. Alam, T. Gomes, H. Zheng, M. M. Mamdani, D. N. Juurlink, and C. M. Bell, “Long-term analgesic use after low-risk surgery,” Archives of Internal Medicine, vol. 172, no. 5, pp. 425–430, 2012. View at Publisher · View at Google Scholar · View at Scopus
  104. M. A. Raebel, S. R. Newcomer, L. M. Reifler et al., “Chronic use of opioid medications before and after bariatric surgery,” JAMA, vol. 310, no. 13, pp. 1369–1376, 2013. View at Publisher · View at Google Scholar · View at Scopus
  105. L. Meyer, J. Lasala, M. Iniesta et al., “Effect of an enhanced recovery after surgery program on opioid use and patient-reported outcomes,” Obstetrics & Gynecology, vol. 132, no. 2, pp. 281–290, 2018. View at Publisher · View at Google Scholar · View at Scopus
  106. I. Kwan, R. Wang, E. Pearce, and S. Bhattacharya, “Pain relief for women undergoing oocyte retrieval for assisted reproduction,” Cochrane Database of Systematic Reviews, vol. 5, Article ID CD004829, 2018. View at Publisher · View at Google Scholar · View at Scopus
  107. K. Ladha, E. Patorno, J. Liu, and B. Bateman, “Impact of perioperative epidural placement on postdischarge opioid use in patients undergoing abdominal surgery,” Anesthesiology, vol. 124, no. 2, pp. 396–403, 2016. View at Publisher · View at Google Scholar · View at Scopus
  108. S. Memtsoudis, J. Poeran, N. Zubizarreta et al., “Association of multimodal pain management strategies with perioperative outcomes and resource utilization,” Anesthesiology, vol. 128, no. 5, pp. 891–902, 2018. View at Publisher · View at Google Scholar · View at Scopus
  109. D. Monks, D. Hoppe, K. Downey, V. Shah, P. Bernstein, and J. C. Carvalho, “A perioperative course of gabapentin does not produce a clinically meaningful improvement in analgesia after cesarean delivery: a randomized controlled trial,” Anesthesiology, vol. 123, no. 2, pp. 320–326, 2015. View at Publisher · View at Google Scholar · View at Scopus
  110. J. T. YaDeau, Y. Lin, D. J. Mayman et al., “Pregabalin and pain after total knee arthroplasty: a double-blind, randomized, placebo-controlled, multidose trial,” British Journal of Anaesthesia, vol. 115, no. 2, pp. 285–293, 2015. View at Publisher · View at Google Scholar · View at Scopus
  111. R. L. Barkin, M. Beckerman, S. L. Blum, F. M. Clark, E.-K. Koh, and D. S. Wu, “Should nonsteroidal anti-inflammatory drugs (NSAIDs) be prescribed to the older adult?” Drugs & Aging, vol. 27, no. 10, pp. 775–789, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. C. Dualé, L. Ouchchane, P. Schoeffler et al., “Neuropathic aspects of persistent postsurgical pain: a French multicenter survey with a 6-month prospective follow-up,” Journal of Pain, vol. 15, no. 1, pp. 24 e21–24 e20, 2014. View at Publisher · View at Google Scholar · View at Scopus
  113. G. W. Jay and R. L. Barkin, “Perspectives on the opioid crisis from pain medicine clinicians,” Disease-a-Month, vol. 64, no. 10, pp. 451–466, 2018. View at Publisher · View at Google Scholar · View at Scopus
  114. T. Gomes, D. N. Juurlink, T. Antoniou, M. M. Mamdani, J. M. Paterson, and W. van den Brink, “Gabapentin, opioids, and the risk of opioid-related death: a population-based nested case-control study,” PLoS Medicine, vol. 14, no. 10, Article ID e1002396, 2017. View at Publisher · View at Google Scholar · View at Scopus
  115. J. Hah, S. C. Mackey, P. Schmidt et al., “Effect of perioperative gabapentin on postoperative pain resolution and opioid cessation in a mixed surgical cohort,” JAMA Surgery, vol. 153, no. 4, pp. 303–311, 2018. View at Publisher · View at Google Scholar · View at Scopus
  116. K. A. Edwards, J. J. Havelin, M. I. Mcintosh et al., “A kappa opioid receptor agonist blocks bone cancer pain without altering bone loss, tumor size, or cancer cell proliferation in a mouse model of cancer-induced bone pain,” Journal of Pain, vol. 19, no. 6, pp. 612–625, 2018. View at Publisher · View at Google Scholar · View at Scopus
  117. Y. Molero, J. Zetterqvist, I. A. Binswanger, C. Hellner, H. Larsson, and S. Fazel, “Medications for alcohol and opioid use disorders and risk of suicidal behavior, accidental overdoses, and crime,” American Journal of Psychiatry, vol. 175, no. 10, pp. 970–978, 2018. View at Publisher · View at Google Scholar · View at Scopus
  118. A. B. Nicholson, G. R. Watson, S. Derry, and P. J. Wiffen, “Methadone for cancer pain,” Cochrane Database of Systematic Reviews, vol. 2, Article ID CD003971, 2017. View at Publisher · View at Google Scholar · View at Scopus
  119. J. W. Boland and A. G. Pockley, “Influence of opioids on immune function in patients with cancer pain: from bench to bedside,” British Journal of Pharmacology, vol. 175, no. 14, pp. 2726–2736, 2018. View at Publisher · View at Google Scholar · View at Scopus
  120. C. M. Jones, G. T. Baldwin, T. Manocchio, J. O. White, and K. A. Mack, “Trends in methadone distribution for pain treatment, methadone diversion, and overdose deaths—United States, 2002–2014,” MMWR. Morbidity and Mortality Weekly Report, vol. 65, no. 26, pp. 667–671, 2016. View at Publisher · View at Google Scholar · View at Scopus
  121. E. M. Hoffman, J. C. Watson, J. St Sauver, N. P. Staff, and C. J. Klein, “Association of long-term opioid therapy with functional status, adverse outcomes, and mortality among patients with polyneuropathy,” JAMA Neurology, vol. 74, no. 7, pp. 773–779, 2017. View at Publisher · View at Google Scholar · View at Scopus
  122. C. Duale, “Prolonged use of opioids after surgery,” British Medical Journal, vol. 348, no. 3, p. g1280, 2014. View at Publisher · View at Google Scholar · View at Scopus
  123. M. Olfson, S. Crystal, M. Wall, S. Wang, S.-M. Liu, and C. Blanco, “Causes of death after nonfatal opioid overdose,” JAMA Psychiatry, vol. 75, no. 8, pp. 820–827, 2018. View at Publisher · View at Google Scholar · View at Scopus
  124. M. Abid Azam, Z. W. Aliza, J. Montbriand et al., “Acceptance and commitment therapy to manage pain and opioid use after major surgery: preliminary outcomes from the toronto general hospital transitional pain service,” Canadian Journal of Pain, vol. 1, no. 1, pp. 1–13, 2017. View at Publisher · View at Google Scholar
  125. A. Z. Weinrib, M. A. Azam, K. A. Birnie, L. C. Burns, H. Clarke, and J. Katz, “The psychology of chronic post-surgical pain: new frontiers in risk factor identification, prevention and management,” British Journal of Pain, vol. 11, no. 4, pp. 169–177, 2017. View at Publisher · View at Google Scholar · View at Scopus
  126. R. Chou, P. T. Korthuis, D. McCarty et al., “Management of suspected opioid overdose with naloxone in out-of-hospital settings,” Annals of Internal Medicine, vol. 167, no. 12, pp. 867–875, 2017. View at Publisher · View at Google Scholar · View at Scopus
  127. A. Kolodny and T. R. Frieden, “Ten steps the federal government should take now to reverse the opioid addiction epidemic,” JAMA, vol. 318, no. 16, pp. 1537-1538, 2017. View at Publisher · View at Google Scholar · View at Scopus
  128. Y. L. Hurd and C. P. O'Brien, “Molecular genetics and new medication strategies for opioid addiction,” American Journal of Psychiatry, vol. 175, no. 10, pp. 935–942, 2018. View at Publisher · View at Google Scholar · View at Scopus
  129. M. E. Olson and K. D. Janda, “Vaccines to combat the opioid crisis,” EMBO Reports, vol. 19, no. 1, pp. 5–9, 2018. View at Publisher · View at Google Scholar · View at Scopus